A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
Clinical trial NCT06237400 · UNKNOWN
Trial details
- NCT number
- NCT06237400
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2025-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.